RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

Published:2017-10-03 Issue:4 Volume:32 Page:931-940
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Jerchel I S,Hoogkamer A Q,Ariës I M,Steeghs E M P,Boer J M,Besselink N J M,Boeree A,van de Ven C,de Groot-Kruseman H A,de Haas V,Horstmann M A,Escherich G,Zwaan C M,Cuppen E,Koudijs M J,Pieters R,den Boer M L

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017303.pdf

Reference64 articles.

1. Pui CH . Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia. Front Med 2015; 9: 1–9.

2. Pui CH, Evans WE . A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol 2013; 50: 185–196.

3. Marshall GM, Dalla Pozza L, Sutton R, Ng A, de Groot-Kruseman HA, van der Velden VH et al. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia 2013; 27: 1497–1503.

4. Pieters R, de Groot-Kruseman H, Van der Velden V, Fiocco M, van den Berg H, de Bont E et al. Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch Childhood Oncology Group. J Clin Oncol 2016; 34: 2591–2601.

5. Klumper E, Pieters R, Veerman AJ, Huismans DR, Loonen AH, Hahlen K et al. In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood 1995; 86: 3861–3868.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-derived rhabdomyosarcoma cells recapitulate the genetic and transcriptomic landscapes of primary tumors;iScience;2024-10

2. Distinct FLT3 Pathways Gene Expression Profiles in Pediatric De Novo Acute Lymphoblastic and Myeloid Leukemia with FLT3 Mutations: Implications for Targeted Therapy;International Journal of Molecular Sciences;2024-09-04

3. Myeloproliferative Neoplasms Transcriptome Reveals Pro-Inflammatory Signature and Enrichment in Peripheral Blood Monocyte-Related Genes;Cancer Investigation;2024-07-03

4. Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations;EJC Paediatric Oncology;2024-06

5. The RAS‐signaling‐pathway‐mutation‐related prognosis in B‐cell acute lymphoblastic leukemia: A report from South China children's leukemia group;Hematological Oncology;2024-04-02